Login / Signup

Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors.

Lucia MusacchioSerena Maria BocciaClaudia MarchettiAngelo MinucciFloriana CamardaChiara CassaniJole VentrigliaVanda SalutariViola GhizzoniElena GiudiceMaria Teresa PerriMaria Vittoria CarboneCaterina RicciSandro PignataAnna FagottiGiovanni ScambiaDomenica Lorusso
Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
pathogenic variants.
Keyphrases
  • wild type
  • dna damage
  • copy number
  • dna repair
  • breast cancer risk
  • newly diagnosed
  • gene expression
  • oxidative stress